Analysis of a second-generation tetracycline antibiotic minocycline in human plasma by LC-MS/MS

Bioanalysis. 2011 Oct;3(19):2177-94. doi: 10.4155/bio.11.226.

Abstract

A simple, selective and sensitive LC-MS/MS assay has been developed for the determination of minocycline in human plasma. Plasma samples were prepared by protein precipitation, followed by chromatographic separation on a HyPURITY™ C8 (100 mm × 4.6 mm, 5 µm) column under isocratic conditions. The LOD and LLOQ of the method were 0.50 and 20.0 ng/ml, respectively. The intra-batch and inter-batch precision (% coefficient of variation) across quality control levels was less than 8.0%. For a set of incurred samples the percentage change in concentration was within ± 9.0%. The method was successfully applied to a bioequivalence study of 135 mg minocycline tablet formulation in 14 healthy Indian males. The reproducibility in the measurement of study data was demonstrated by incurred sample reanalysis.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / blood*
  • Anti-Bacterial Agents / pharmacokinetics
  • Calibration
  • Chromatography, Liquid / methods*
  • Humans
  • Male
  • Mass Spectrometry / methods*
  • Minocycline / administration & dosage
  • Minocycline / blood*
  • Minocycline / pharmacokinetics
  • Quality Control
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Anti-Bacterial Agents
  • Minocycline